Why the study?
Does continuous intravenous epoprostenol improve clinical and haemodynamic responses in patients with chronic thromboembolic pulmonary hypertension prior to pulmonary thromboendarterectomy?
Population
9 patients with chronic thromboembolic pulmonary hypertension who subsequently underwent pulmonary…
Design
Case_series
Follow-up
2 to 26 months
Authors
Loading...
May support epoprostenol in select CTEPH pre-PTE; leaves open need for controlled trials.
Does continuous intravenous epoprostenol improve clinical and haemodynamic responses in patients with chronic thromboembolic pulmonary hypertension prior to pulmonary thromboendarterectomy?
Continuous intravenous epoprostenol may provide clinical and haemodynamic benefits for selected patients with chronic thromboembolic pulmonary hypertension prior to pulmonary thromboendarterectomy.
Bresser et al. (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: